![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 231/12 | |
A61K 31/415 | |||
A61P 7/00 |
(11) | Number of the document | 2018372 |
(13) | Kind of document | T |
(96) | European patent application number | 07794969.1 |
Date of filing the European patent application | 2007-05-17 | |
(97) | Date of publication of the European application | 2009-01-28 |
(45) | Date of publication and mention of the grant of the patent | 2015-05-13 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2007/011810 |
Date | 2007-05-17 |
(87) | Number | WO 2007/136689 |
Date | 2007-11-29 |
(30) | Number | Date | Country code |
801789 P | 2006-05-18 | US | |
921318 P | 2007-04-02 | US |
(72) |
GHARBAOUI, Tawfik, US
SENGUPTA, Dipanjan, US
KRISHNAN, Ashwin M., US
SHAH, Nainesh, US
MACIAS, Mark, US
HART, Ryan M., US
LALLY, Edward A., US
DUFFIELD, Jonathan J, US
|
(73) |
Arena Pharmaceuticals, Inc.,
6154 Nancy Ridge Drive, San Diego, CA 92121,
US
|
(54) | CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF PHENYL-PYRAZOLES USEFUL AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR |
CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF PHENYL-PYRAZOLES USEFUL AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR |